By Rhonda Quintana, Ceresti Chief Revenue Officer

‍

If you lead an accountable care organization (ACO), you’ve likely heard of CMS’s GUIDE (Guiding an Improved Dementia Experience) model. It’s an eight-year initiative designed to improve dementia care by integrating family caregivers into the care team. It is also a battle cry for better care. Ignore it at your own peril.

Many ACOs have dismissed GUIDE, viewing it as a financial burden. At first glance, the math seems to justify this: GUIDE payments of approximately $2,000 per patient annually could increase medical expenditures and reduce shared savings. Rational, right?

Wrong.

Doing nothing is not a neutral decision. Any GUIDE participant can enroll your dementia patients—without your input. If they fail to generate cost savings greater than GUIDE payments, your shared savings will take the hit. Worse, the care fragmentation caused by provider-centric GUIDE participants could jeopardize attribution and your ability to manage patient care effectively.

The solution? Take control. Proactively enroll your dementia patients with a GUIDE partner that prioritizes cost savings and patient retention.

Why Ceresti?
Ceresti is not just another GUIDE participant—it’s a proven partner. With nearly a decade of experience in dementia care for Medicare Advantage plans, Ceresti’s technology-enabled model consistently delivers results:

• Validated cost savings of 30%+ ($7,000 per patient annually).
• A guarantee: Ceresti ensures that its cost savings exceed GUIDE payments, eliminating downside risks for your ACO.

By partnering with Ceresti, you empower your primary care teams, protect patient attribution and maximize shared savings.

The Bottom Line
Ignoring GUIDE risks increased costs, lost patients and fragmented care. Ceresti ensures better care, reduced risks and measurable financial gains for your ACO.

Doing nothing is not free. But choosing the right partner is.

‍